NEW YORK - Metastatic melanoma of the brain has a terrible prognosis, with a median survival of three to four months.
Establishing a Culture of Respect: Responding to Patient-Initiated Harassment
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity
New Advancements in Surgical Scar Revision